Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Depreciation and Depletion: 2020-2025

Historic Depreciation and Depletion for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Mar 2025 value amounting to $153,000.

  • Arcutis Biotherapeutics' Depreciation and Depletion fell 10.00% to $153,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $623,000, marking a year-over-year decrease of 21.64%. This contributed to the annual value of $640,000 for FY2024, which is 20.00% down from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Depreciation and Depletion of $153,000 as of Q1 2025, which was up 5.52% from $145,000 recorded in Q4 2024.
  • Over the past 5 years, Arcutis Biotherapeutics' Depreciation and Depletion peaked at $227,000 during Q4 2023, and registered a low of $98,000 during Q1 2021.
  • For the 3-year period, Arcutis Biotherapeutics' Depreciation and Depletion averaged around $177,000, with its median value being $170,000 (2024).
  • In the last 5 years, Arcutis Biotherapeutics' Depreciation and Depletion surged by 420.00% in 2021 and then crashed by 36.12% in 2024.
  • Arcutis Biotherapeutics' Depreciation and Depletion (Quarterly) stood at $182,000 in 2021, then declined by 12.09% to $160,000 in 2022, then spiked by 41.87% to $227,000 in 2023, then tumbled by 36.12% to $145,000 in 2024, then dropped by 10.00% to $153,000 in 2025.
  • Its Depreciation and Depletion was $153,000 in Q1 2025, compared to $145,000 in Q4 2024 and $161,000 in Q3 2024.